Gladstone Institutional Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.73M Buy
30,853
+1,314
+4% +$244K 0.24% 101
2025
Q1
$6.19M Buy
29,539
+1,810
+7% +$379K 0.29% 85
2024
Q4
$4.93M Buy
27,729
+6
+0% +$1.07K 0.23% 101
2024
Q3
$5.47M Sell
27,723
-328
-1% -$64.8K 0.27% 94
2024
Q2
$4.81M Buy
28,051
+2,261
+9% +$388K 0.25% 107
2024
Q1
$4.7M Buy
25,790
+3,427
+15% +$624K 0.26% 106
2023
Q4
$3.47M Buy
22,363
+1,325
+6% +$205K 0.19% 135
2023
Q3
$3.14M Buy
21,038
+1,551
+8% +$231K 0.2% 128
2023
Q2
$2.63M Sell
19,487
-3,239
-14% -$436K 0.16% 163
2023
Q1
$3.62M Sell
22,726
-1,230
-5% -$196K 0.23% 127
2022
Q4
$3.87M Sell
23,956
-4,169
-15% -$674K 0.27% 106
2022
Q3
$3.78M Sell
28,125
-9,588
-25% -$1.29M 0.3% 86
2022
Q2
$5.78M Sell
37,713
-8,753
-19% -$1.34M 0.46% 45
2022
Q1
$7.53M Buy
46,466
+24,792
+114% +$4.02M 0.51% 40
2021
Q4
$2.94M Buy
21,674
+6,190
+40% +$838K 0.23% 120
2021
Q3
$1.67M Sell
15,484
-813
-5% -$87.7K 0.16% 165
2021
Q2
$1.84M Buy
16,297
+4,603
+39% +$519K 0.22% 116
2021
Q1
$1.27M Buy
11,694
+3,805
+48% +$412K 0.2% 114
2020
Q4
$845K Sell
7,889
-672
-8% -$72K 0.17% 119
2020
Q3
$750K Sell
8,561
-8,596
-50% -$753K 0.18% 114
2020
Q2
$1.68M Buy
17,157
+5,374
+46% +$527K 0.43% 57
2020
Q1
$898K Buy
11,783
+3,106
+36% +$237K 0.23% 91
2019
Q4
$768K Sell
8,677
-3,166
-27% -$280K 0.19% 103
2019
Q3
$897K Sell
11,843
-187
-2% -$14.2K 0.23% 92
2019
Q2
$875K Buy
12,030
+8,469
+238% +$616K 0.27% 83
2019
Q1
$287K Sell
3,561
-107
-3% -$8.62K 0.11% 157
2018
Q4
$338K Buy
+3,668
New +$338K 0.2% 117